カテゴリー： QYResearch, 世界

世界のマイトジェン活性化プロテインキナーゼ14市場 2019年

【英語タイトル】Global Mitogen Activated Protein Kinase 14 Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X11516）・商品コード：DATA909X11516
・発行会社（調査会社）：QYResearch
・発行日：2019年11月20日（※2024年版があります。お問い合わせください）
・ページ数：101
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、マイトジェン活性化プロテインキナーゼ14の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、メシル酸ラリメチニブ、ロスマピモド、ネフラマピモド、CHF-6297、その他に、用途別には、慢性炎症、潰瘍性大腸炎、上皮性卵巣がん、胃がん、その他にセグメント区分し、マイトジェン活性化プロテインキナーゼ14の世界市場を分析しました。


・エグゼクティブ・サマリー
・マイトジェン活性化プロテインキナーゼ14の世界市場概要
・マイトジェン活性化プロテインキナーゼ14の製造コスト構成分析
・マイトジェン活性化プロテインキナーゼ14の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・マイトジェン活性化プロテインキナーゼ14の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マイトジェン活性化プロテインキナーゼ14のセグメント分析（種類別）
（メシル酸ラリメチニブ、ロスマピモド、ネフラマピモド、CHF-6297、その他）
・マイトジェン活性化プロテインキナーゼ14のセグメント分析（用途別）
（慢性炎症、潰瘍性大腸炎、上皮性卵巣がん、胃がん、その他）
・マイトジェン活性化プロテインキナーゼ14の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Array BioPharma Inc.、Astellas Pharma Inc.、AstraZeneca Plc、Chiesi Farmaceutici SpA、Chroma Therapeutics Limited、Eli Lilly and Company、GlaxoSmithKline Plc、Synovo GmbH、Toray Industries、Zocere, Inc.、）
・マイトジェン活性化プロテインキナーゼ14の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Mitogen Activated Protein Kinase 14 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Mitogen Activated Protein Kinase 14 volume and value at global level, regional level and company level. From a global perspective, this report represents overall Mitogen Activated Protein Kinase 14 market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Mitogen Activated Protein Kinase 14 in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Mitogen Activated Protein Kinase 14 manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Array BioPharma Inc.
Astellas Pharma Inc.
AstraZeneca Plc
Chiesi Farmaceutici SpA
Chroma Therapeutics Limited
Eli Lilly and Company
GlaxoSmithKline Plc
Synovo GmbH
Toray Industries
Zocere, Inc.

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Ralimetinib Mesylate
Losmapimod
Neflamapimod
CHF-6297
Others

Segment by Application
Chronic Inflammation
Ulcerative Colitis
Epithelial Ovarian Cancer
Gastric Cancer
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Mitogen Activated Protein Kinase 14
1.1 Definition of Mitogen Activated Protein Kinase 14
1.2 Mitogen Activated Protein Kinase 14 Segment by Type
1.2.1 Global Mitogen Activated Protein Kinase 14 Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Ralimetinib Mesylate
1.2.3 Losmapimod
1.2.4 Neflamapimod
1.2.5 CHF-6297
1.2.6 Others
1.3 Mitogen Activated Protein Kinase 14 Segment by Applications
1.3.1 Global Mitogen Activated Protein Kinase 14 Consumption Comparison by Applications (2014-2025)
1.3.2 Chronic Inflammation
1.3.3 Ulcerative Colitis
1.3.4 Epithelial Ovarian Cancer
1.3.5 Gastric Cancer
1.3.6 Others
1.4 Global Mitogen Activated Protein Kinase 14 Overall Market
1.4.1 Global Mitogen Activated Protein Kinase 14 Revenue (2014-2025)
1.4.2 Global Mitogen Activated Protein Kinase 14 Production (2014-2025)
1.4.3 North America Mitogen Activated Protein Kinase 14 Status and Prospect (2014-2025)
1.4.4 Europe Mitogen Activated Protein Kinase 14 Status and Prospect (2014-2025)
1.4.5 China Mitogen Activated Protein Kinase 14 Status and Prospect (2014-2025)
1.4.6 Japan Mitogen Activated Protein Kinase 14 Status and Prospect (2014-2025)
1.4.7 Southeast Asia Mitogen Activated Protein Kinase 14 Status and Prospect (2014-2025)
1.4.8 India Mitogen Activated Protein Kinase 14 Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Mitogen Activated Protein Kinase 14
2.3 Manufacturing Process Analysis of Mitogen Activated Protein Kinase 14
2.4 Industry Chain Structure of Mitogen Activated Protein Kinase 14

3 Development and Manufacturing Plants Analysis of Mitogen Activated Protein Kinase 14
3.1 Capacity and Commercial Production Date
3.2 Global Mitogen Activated Protein Kinase 14 Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Mitogen Activated Protein Kinase 14
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Mitogen Activated Protein Kinase 14 Production and Capacity Analysis
4.2 Mitogen Activated Protein Kinase 14 Revenue Analysis
4.3 Mitogen Activated Protein Kinase 14 Price Analysis
4.4 Market Concentration Degree

5 Mitogen Activated Protein Kinase 14 Regional Market Analysis
5.1 Mitogen Activated Protein Kinase 14 Production by Regions
5.1.1 Global Mitogen Activated Protein Kinase 14 Production by Regions
5.1.2 Global Mitogen Activated Protein Kinase 14 Revenue by Regions
5.2 Mitogen Activated Protein Kinase 14 Consumption by Regions
5.3 North America Mitogen Activated Protein Kinase 14 Market Analysis
5.3.1 North America Mitogen Activated Protein Kinase 14 Production
5.3.2 North America Mitogen Activated Protein Kinase 14 Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Mitogen Activated Protein Kinase 14 Import and Export
5.4 Europe Mitogen Activated Protein Kinase 14 Market Analysis
5.4.1 Europe Mitogen Activated Protein Kinase 14 Production
5.4.2 Europe Mitogen Activated Protein Kinase 14 Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Mitogen Activated Protein Kinase 14 Import and Export
5.5 China Mitogen Activated Protein Kinase 14 Market Analysis
5.5.1 China Mitogen Activated Protein Kinase 14 Production
5.5.2 China Mitogen Activated Protein Kinase 14 Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Mitogen Activated Protein Kinase 14 Import and Export
5.6 Japan Mitogen Activated Protein Kinase 14 Market Analysis
5.6.1 Japan Mitogen Activated Protein Kinase 14 Production
5.6.2 Japan Mitogen Activated Protein Kinase 14 Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Mitogen Activated Protein Kinase 14 Import and Export
5.7 Southeast Asia Mitogen Activated Protein Kinase 14 Market Analysis
5.7.1 Southeast Asia Mitogen Activated Protein Kinase 14 Production
5.7.2 Southeast Asia Mitogen Activated Protein Kinase 14 Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Mitogen Activated Protein Kinase 14 Import and Export
5.8 India Mitogen Activated Protein Kinase 14 Market Analysis
5.8.1 India Mitogen Activated Protein Kinase 14 Production
5.8.2 India Mitogen Activated Protein Kinase 14 Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Mitogen Activated Protein Kinase 14 Import and Export

6 Mitogen Activated Protein Kinase 14 Segment Market Analysis (by Type)
6.1 Global Mitogen Activated Protein Kinase 14 Production by Type
6.2 Global Mitogen Activated Protein Kinase 14 Revenue by Type
6.3 Mitogen Activated Protein Kinase 14 Price by Type

7 Mitogen Activated Protein Kinase 14 Segment Market Analysis (by Application)
7.1 Global Mitogen Activated Protein Kinase 14 Consumption by Application
7.2 Global Mitogen Activated Protein Kinase 14 Consumption Market Share by Application (2014-2019)

8 Mitogen Activated Protein Kinase 14 Major Manufacturers Analysis
8.1 Array BioPharma Inc.
8.1.1 Array BioPharma Inc. Mitogen Activated Protein Kinase 14 Production Sites and Area Served
8.1.2 Array BioPharma Inc. Product Introduction, Application and Specification
8.1.3 Array BioPharma Inc. Mitogen Activated Protein Kinase 14 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Astellas Pharma Inc.
8.2.1 Astellas Pharma Inc. Mitogen Activated Protein Kinase 14 Production Sites and Area Served
8.2.2 Astellas Pharma Inc. Product Introduction, Application and Specification
8.2.3 Astellas Pharma Inc. Mitogen Activated Protein Kinase 14 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 AstraZeneca Plc
8.3.1 AstraZeneca Plc Mitogen Activated Protein Kinase 14 Production Sites and Area Served
8.3.2 AstraZeneca Plc Product Introduction, Application and Specification
8.3.3 AstraZeneca Plc Mitogen Activated Protein Kinase 14 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Chiesi Farmaceutici SpA
8.4.1 Chiesi Farmaceutici SpA Mitogen Activated Protein Kinase 14 Production Sites and Area Served
8.4.2 Chiesi Farmaceutici SpA Product Introduction, Application and Specification
8.4.3 Chiesi Farmaceutici SpA Mitogen Activated Protein Kinase 14 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Chroma Therapeutics Limited
8.5.1 Chroma Therapeutics Limited Mitogen Activated Protein Kinase 14 Production Sites and Area Served
8.5.2 Chroma Therapeutics Limited Product Introduction, Application and Specification
8.5.3 Chroma Therapeutics Limited Mitogen Activated Protein Kinase 14 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Eli Lilly and Company
8.6.1 Eli Lilly and Company Mitogen Activated Protein Kinase 14 Production Sites and Area Served
8.6.2 Eli Lilly and Company Product Introduction, Application and Specification
8.6.3 Eli Lilly and Company Mitogen Activated Protein Kinase 14 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 GlaxoSmithKline Plc
8.7.1 GlaxoSmithKline Plc Mitogen Activated Protein Kinase 14 Production Sites and Area Served
8.7.2 GlaxoSmithKline Plc Product Introduction, Application and Specification
8.7.3 GlaxoSmithKline Plc Mitogen Activated Protein Kinase 14 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Synovo GmbH
8.8.1 Synovo GmbH Mitogen Activated Protein Kinase 14 Production Sites and Area Served
8.8.2 Synovo GmbH Product Introduction, Application and Specification
8.8.3 Synovo GmbH Mitogen Activated Protein Kinase 14 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Toray Industries
8.9.1 Toray Industries Mitogen Activated Protein Kinase 14 Production Sites and Area Served
8.9.2 Toray Industries Product Introduction, Application and Specification
8.9.3 Toray Industries Mitogen Activated Protein Kinase 14 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Zocere, Inc.
8.10.1 Zocere, Inc. Mitogen Activated Protein Kinase 14 Production Sites and Area Served
8.10.2 Zocere, Inc. Product Introduction, Application and Specification
8.10.3 Zocere, Inc. Mitogen Activated Protein Kinase 14 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served

9 Development Trend of Analysis of Mitogen Activated Protein Kinase 14 Market
9.1 Global Mitogen Activated Protein Kinase 14 Market Trend Analysis
9.1.1 Global Mitogen Activated Protein Kinase 14 Market Size (Volume and Value) Forecast 2019-2025
9.2 Mitogen Activated Protein Kinase 14 Regional Market Trend
9.2.1 North America Mitogen Activated Protein Kinase 14 Forecast 2019-2025
9.2.2 Europe Mitogen Activated Protein Kinase 14 Forecast 2019-2025
9.2.3 China Mitogen Activated Protein Kinase 14 Forecast 2019-2025
9.2.4 Japan Mitogen Activated Protein Kinase 14 Forecast 2019-2025
9.2.5 Southeast Asia Mitogen Activated Protein Kinase 14 Forecast 2019-2025
9.2.6 India Mitogen Activated Protein Kinase 14 Forecast 2019-2025
9.3 Mitogen Activated Protein Kinase 14 Market Trend (Product Type)
9.4 Mitogen Activated Protein Kinase 14 Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Mitogen Activated Protein Kinase 14 Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Mitogen Activated Protein Kinase 14
Table Global Mitogen Activated Protein Kinase 14 Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Mitogen Activated Protein Kinase 14 Production Market Share by Types in 2018
Figure Ralimetinib Mesylate Product Picture
Figure Losmapimod Product Picture
Figure Neflamapimod Product Picture
Figure CHF-6297 Product Picture
Figure Others Product Picture
Table Global Mitogen Activated Protein Kinase 14 Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Mitogen Activated Protein Kinase 14 Consumption Market Share by Applications in 2018
Figure Chronic Inflammation
Figure Ulcerative Colitis
Figure Epithelial Ovarian Cancer
Figure Gastric Cancer
Figure Others
Figure Global Mitogen Activated Protein Kinase 14 Revenue (Million USD) (2014-2025)
Figure Global Mitogen Activated Protein Kinase 14 Production (K Pcs) (2014-2025)
Figure North America Mitogen Activated Protein Kinase 14 Market Size (Million USD) (2014-2025)
Figure Europe Mitogen Activated Protein Kinase 14 Market Size (Million USD) (2014-2025)
Figure China Mitogen Activated Protein Kinase 14 Market Size (Million USD) (2014-2025)
Figure Japan Mitogen Activated Protein Kinase 14 Market Size (Million USD) (2014-2025)
Figure Southeast Asia Mitogen Activated Protein Kinase 14 Market Size (Million USD) (2014-2025)
Figure India Mitogen Activated Protein Kinase 14 Market Size (Million USD) (2014-2025)
Table Mitogen Activated Protein Kinase 14 Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Mitogen Activated Protein Kinase 14 in 2018
Figure Manufacturing Process Analysis of Mitogen Activated Protein Kinase 14
Figure Industry Chain Structure of Mitogen Activated Protein Kinase 14
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Mitogen Activated Protein Kinase 14 Manufacturing Plants Distribution
Table Mitogen Activated Protein Kinase 14 Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Mitogen Activated Protein Kinase 14 Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Mitogen Activated Protein Kinase 14 Production (K Pcs) of Major Manufacturers (2014-2019)
Table Mitogen Activated Protein Kinase 14 Production Market Share of Major Manufacturers (2014-2019)
Figure Mitogen Activated Protein Kinase 14 Production Share by Manufacturers in 2018
Table Mitogen Activated Protein Kinase 14 Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Mitogen Activated Protein Kinase 14 Revenue Market Share of Major Manufacturers (2014-2019)
Figure Mitogen Activated Protein Kinase 14 Revenue Share by Manufacturers in 2018
Table Mitogen Activated Protein Kinase 14 Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Mitogen Activated Protein Kinase 14 Production by Regions 2014-2019 (K Pcs)
Table Global Mitogen Activated Protein Kinase 14 Production Market Share by Regions 2014-2019
Figure Global Mitogen Activated Protein Kinase 14 Production Market Share by Regions in 2018
Table Global Mitogen Activated Protein Kinase 14 Revenue by Regions 2014-2019 (Million USD)
Table Global Mitogen Activated Protein Kinase 14 Revenue Market Share by Regions 2014-2019
Figure Global Mitogen Activated Protein Kinase 14 Revenue Market Share by Regions in 2018
Table Global Mitogen Activated Protein Kinase 14 Consumption by Regions 2014-2019 (K Pcs)
Table Global Mitogen Activated Protein Kinase 14 Consumption Market Share by Regions 2014-2019
Figure North America Mitogen Activated Protein Kinase 14 Production Growth Rate 2014-2019 (K Pcs)
Figure North America Mitogen Activated Protein Kinase 14 Revenue Growth Rate 2014-2019 (Million USD)
Table North America Mitogen Activated Protein Kinase 14 Production, Consumption Import and Export (K Pcs)
Figure Europe Mitogen Activated Protein Kinase 14 Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Mitogen Activated Protein Kinase 14 Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Mitogen Activated Protein Kinase 14 Production, Consumption Import and Export (K Pcs)
Figure China Mitogen Activated Protein Kinase 14 Production Growth Rate 2014-2019 (K Pcs)
Figure China Mitogen Activated Protein Kinase 14 Revenue Growth Rate 2014-2019 (Million USD)
Table China Mitogen Activated Protein Kinase 14 Production, Consumption Import and Export (K Pcs)
Figure Japan Mitogen Activated Protein Kinase 14 Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Mitogen Activated Protein Kinase 14 Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Mitogen Activated Protein Kinase 14 Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Mitogen Activated Protein Kinase 14 Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Mitogen Activated Protein Kinase 14 Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Mitogen Activated Protein Kinase 14 Production, Consumption Import and Export (K Pcs)
Figure India Mitogen Activated Protein Kinase 14 Production Growth Rate 2014-2019 (K Pcs)
Figure India Mitogen Activated Protein Kinase 14 Revenue Growth Rate 2014-2019 (Million USD)
Table India Mitogen Activated Protein Kinase 14 Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Mitogen Activated Protein Kinase 14 Market Share by Application (2014-2019)
Figure Global Value (Consumption) Mitogen Activated Protein Kinase 14 Market Share by Application (2014-2019)
Table Array BioPharma Inc. Mitogen Activated Protein Kinase 14 Production Sites and Area Served
Table Array BioPharma Inc. Mitogen Activated Protein Kinase 14 Product Introduction, Application and Specification
Table Array BioPharma Inc. Mitogen Activated Protein Kinase 14 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Array BioPharma Inc. Mitogen Activated Protein Kinase 14 Production Growth Rate (2014-2019)
Table Array BioPharma Inc. Mitogen Activated Protein Kinase 14 Production Market Share (2014-2019)
Figure Array BioPharma Inc. Mitogen Activated Protein Kinase 14 Revenue Market Share (2014-2019)
Table Array BioPharma Inc. Mitogen Activated Protein Kinase 14 Main Business and Markets Served
Table Astellas Pharma Inc. Mitogen Activated Protein Kinase 14 Production Sites and Area Served
Table Astellas Pharma Inc. Mitogen Activated Protein Kinase 14 Product Introduction, Application and Specification
Table Astellas Pharma Inc. Mitogen Activated Protein Kinase 14 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Astellas Pharma Inc. Mitogen Activated Protein Kinase 14 Production Growth Rate (2014-2019)
Table Astellas Pharma Inc. Mitogen Activated Protein Kinase 14 Production Market Share (2014-2019)
Figure Astellas Pharma Inc. Mitogen Activated Protein Kinase 14 Revenue Market Share (2014-2019)
Table Astellas Pharma Inc. Mitogen Activated Protein Kinase 14 Main Business and Markets Served
Table AstraZeneca Plc Mitogen Activated Protein Kinase 14 Production Sites and Area Served
Table AstraZeneca Plc Mitogen Activated Protein Kinase 14 Product Introduction, Application and Specification
Table AstraZeneca Plc Mitogen Activated Protein Kinase 14 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table AstraZeneca Plc Mitogen Activated Protein Kinase 14 Production Growth Rate (2014-2019)
Table AstraZeneca Plc Mitogen Activated Protein Kinase 14 Production Market Share (2014-2019)
Figure AstraZeneca Plc Mitogen Activated Protein Kinase 14 Revenue Market Share (2014-2019)
Table AstraZeneca Plc Mitogen Activated Protein Kinase 14 Main Business and Markets Served
Table Chiesi Farmaceutici SpA Mitogen Activated Protein Kinase 14 Production Sites and Area Served
Table Chiesi Farmaceutici SpA Mitogen Activated Protein Kinase 14 Product Introduction, Application and Specification
Table Chiesi Farmaceutici SpA Mitogen Activated Protein Kinase 14 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Chiesi Farmaceutici SpA Mitogen Activated Protein Kinase 14 Production Growth Rate (2014-2019)
Table Chiesi Farmaceutici SpA Mitogen Activated Protein Kinase 14 Production Market Share (2014-2019)
Figure Chiesi Farmaceutici SpA Mitogen Activated Protein Kinase 14 Revenue Market Share (2014-2019)
Table Chiesi Farmaceutici SpA Mitogen Activated Protein Kinase 14 Main Business and Markets Served
Table Chroma Therapeutics Limited Mitogen Activated Protein Kinase 14 Production Sites and Area Served
Table Chroma Therapeutics Limited Mitogen Activated Protein Kinase 14 Product Introduction, Application and Specification
Table Chroma Therapeutics Limited Mitogen Activated Protein Kinase 14 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Chroma Therapeutics Limited Mitogen Activated Protein Kinase 14 Production Growth Rate (2014-2019)
Table Chroma Therapeutics Limited Mitogen Activated Protein Kinase 14 Production Market Share (2014-2019)
Figure Chroma Therapeutics Limited Mitogen Activated Protein Kinase 14 Revenue Market Share (2014-2019)
Table Chroma Therapeutics Limited Mitogen Activated Protein Kinase 14 Main Business and Markets Served
Table Eli Lilly and Company Mitogen Activated Protein Kinase 14 Production Sites and Area Served
Table Eli Lilly and Company Mitogen Activated Protein Kinase 14 Product Introduction, Application and Specification
Table Eli Lilly and Company Mitogen Activated Protein Kinase 14 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Eli Lilly and Company Mitogen Activated Protein Kinase 14 Production Growth Rate (2014-2019)
Table Eli Lilly and Company Mitogen Activated Protein Kinase 14 Production Market Share (2014-2019)
Figure Eli Lilly and Company Mitogen Activated Protein Kinase 14 Revenue Market Share (2014-2019)
Table Eli Lilly and Company Mitogen Activated Protein Kinase 14 Main Business and Markets Served
Table GlaxoSmithKline Plc Mitogen Activated Protein Kinase 14 Production Sites and Area Served
Table GlaxoSmithKline Plc Mitogen Activated Protein Kinase 14 Product Introduction, Application and Specification
Table GlaxoSmithKline Plc Mitogen Activated Protein Kinase 14 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table GlaxoSmithKline Plc Mitogen Activated Protein Kinase 14 Production Growth Rate (2014-2019)
Table GlaxoSmithKline Plc Mitogen Activated Protein Kinase 14 Production Market Share (2014-2019)
Figure GlaxoSmithKline Plc Mitogen Activated Protein Kinase 14 Revenue Market Share (2014-2019)
Table GlaxoSmithKline Plc Mitogen Activated Protein Kinase 14 Main Business and Markets Served
Table Synovo GmbH Mitogen Activated Protein Kinase 14 Production Sites and Area Served
Table Synovo GmbH Mitogen Activated Protein Kinase 14 Product Introduction, Application and Specification
Table Synovo GmbH Mitogen Activated Protein Kinase 14 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Synovo GmbH Mitogen Activated Protein Kinase 14 Production Growth Rate (2014-2019)
Table Synovo GmbH Mitogen Activated Protein Kinase 14 Production Market Share (2014-2019)
Figure Synovo GmbH Mitogen Activated Protein Kinase 14 Revenue Market Share (2014-2019)
Table Synovo GmbH Mitogen Activated Protein Kinase 14 Main Business and Markets Served
Table Toray Industries Mitogen Activated Protein Kinase 14 Production Sites and Area Served
Table Toray Industries Mitogen Activated Protein Kinase 14 Product Introduction, Application and Specification
Table Toray Industries Mitogen Activated Protein Kinase 14 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Toray Industries Mitogen Activated Protein Kinase 14 Production Growth Rate (2014-2019)
Table Toray Industries Mitogen Activated Protein Kinase 14 Production Market Share (2014-2019)
Figure Toray Industries Mitogen Activated Protein Kinase 14 Revenue Market Share (2014-2019)
Table Toray Industries Mitogen Activated Protein Kinase 14 Main Business and Markets Served
Table Zocere, Inc. Mitogen Activated Protein Kinase 14 Production Sites and Area Served
Table Zocere, Inc. Mitogen Activated Protein Kinase 14 Product Introduction, Application and Specification
Table Zocere, Inc. Mitogen Activated Protein Kinase 14 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Zocere, Inc. Mitogen Activated Protein Kinase 14 Production Growth Rate (2014-2019)
Table Zocere, Inc. Mitogen Activated Protein Kinase 14 Production Market Share (2014-2019)
Figure Zocere, Inc. Mitogen Activated Protein Kinase 14 Revenue Market Share (2014-2019)
Table Zocere, Inc. Mitogen Activated Protein Kinase 14 Main Business and Markets Served
Figure Global Mitogen Activated Protein Kinase 14 Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Mitogen Activated Protein Kinase 14 Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Mitogen Activated Protein Kinase 14 Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Mitogen Activated Protein Kinase 14 Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Mitogen Activated Protein Kinase 14 Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Mitogen Activated Protein Kinase 14 Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Mitogen Activated Protein Kinase 14 Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Mitogen Activated Protein Kinase 14 Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Mitogen Activated Protein Kinase 14 Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Mitogen Activated Protein Kinase 14 Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Mitogen Activated Protein Kinase 14 Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Mitogen Activated Protein Kinase 14 Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Mitogen Activated Protein Kinase 14 Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Mitogen Activated Protein Kinase 14 Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Mitogen Activated Protein Kinase 14 Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Mitogen Activated Protein Kinase 14 by Type (2019-2025)
Table Global Consumption (K Pcs) of Mitogen Activated Protein Kinase 14 by Application (2019-2025)
Table Mitogen Activated Protein Kinase 14 Distributors List
Table Mitogen Activated Protein Kinase 14 Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Array BioPharma Inc.、Astellas Pharma Inc.、AstraZeneca Plc、Chiesi Farmaceutici SpA、Chroma Therapeutics Limited、Eli Lilly and Company、GlaxoSmithKline Plc、Synovo GmbH、Toray Industries、Zocere, Inc.、

★調査レポート[世界のマイトジェン活性化プロテインキナーゼ14市場 2019年] (コード：DATA909X11516)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のマイトジェン活性化プロテインキナーゼ14市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のマイトジェン活性化プロテインキナーゼ1市場 2019年
    DATA909X11515 / QYResearch / 2019年11月20日 / ※本調査レポートは、マイトジェン活性化プロテインキナーゼ1の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、CB-745、JRP-890、KO-947、LY-3214996、その他に、用途別には、膵管腺がん、固形腫瘍、結腸がん、乳がん、その他にセグメント区分し、マイトジェン活性化プロテインキナーゼ1の世界市場を分析しました。 ・エグゼクティブ・サマリー ・マイトジェン活性化プロテインキナーゼ1の世界市場概要 ・マイトジェン活性化プロテインキナーゼ1の製造コスト構成分析 ・マイトジェン活性化プロテインキナーゼ1の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・マイトジェン活性化プロテインキナーゼ1の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・マイトジェン活性化プロテインキナーゼ1のセグメント分析（種類別） （CB-745、JRP-890、KO-947、LY-3214996、その他）...The global Mitogen Activated Protein Kinase 1 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Mitogen Activated Protein Kinase 1 volume and value at global level, regional level and company level. From a global perspective, this report represents overall Mitogen Activated Protein Kinase 1 market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Mitogen Activated Protein Kinase 1 in North America, Europe, China, Japan, Southeast Asia and...
  • 世界のMAPキナーゼ相互作用セリンプロテインキナーゼ1市場 2019年
    DATA909X10957 / QYResearch / 2019年11月20日 / ※本調査レポートは、MAPキナーゼ相互作用セリンプロテインキナーゼ1の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、セルスコスポラミド、eFT-508、ETC-027、ETC-17804452、その他に、用途別には、遺伝性疾患、脆弱X症候群、リンパ腫、その他にセグメント区分し、MAPキナーゼ相互作用セリンプロテインキナーゼ1の世界市場を分析しました。 ・エグゼクティブ・サマリー ・MAPキナーゼ相互作用セリンプロテインキナーゼ1の世界市場概要 ・MAPキナーゼ相互作用セリンプロテインキナーゼ1の製造コスト構成分析 ・MAPキナーゼ相互作用セリンプロテインキナーゼ1の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・MAPキナーゼ相互作用セリンプロテインキナーゼ1の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・MAPキナーゼ相互作用セリンプロテインキナーゼ1のセグメント分析（種類別） （セルスコスポラミド、eFT-508、ETC-027、ETC-17804452、その他）...The global MAP Kinase Interacting Serine Protein Kinase 1 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on MAP Kinase Interacting Serine Protein Kinase 1 volume and value at global level, regional level and company level. From a global perspective, this report represents overall MAP Kinase Interacting Serine Protein Kinase 1 market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of MAP Kinase Interacting Serine Protein Kinase 1 in...
  • 世界のプロテインキナーゼCイプシロンタイプ市場 2019年
    DATA909X13843 / QYResearch / 2019年11月20日 / ※本調査レポートは、プロテインキナーゼCイプシロンタイプの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ブリオスタチン-1、DHACP-6、VMD-1201、その他に、用途別には、アルコール中毒、頭頸部がん、虚血性脳卒中、神経学、その他にセグメント区分し、プロテインキナーゼCイプシロンタイプの世界市場を分析しました。 ・エグゼクティブ・サマリー ・プロテインキナーゼCイプシロンタイプの世界市場概要 ・プロテインキナーゼCイプシロンタイプの製造コスト構成分析 ・プロテインキナーゼCイプシロンタイプの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・プロテインキナーゼCイプシロンタイプの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・プロテインキナーゼCイプシロンタイプのセグメント分析（種類別） （ブリオスタチン-1、DHACP-6、VMD-1201、その他）...The global Protein Kinase C Epsilon Type market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Protein Kinase C Epsilon Type volume and value at global level, regional level and company level. From a global perspective, this report represents overall Protein Kinase C Epsilon Type market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Protein Kinase C Epsilon Type in North America, Europe, China, Japan, Southeast Asia and...
  • 世界のセリンプロテインキナーゼ市場 2019年
    DATA909X14915 / QYResearch / 2019年11月20日 / ※本調査レポートは、セリンプロテインキナーゼの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、AZD-0156、AZD-1390、KU-55933、M-3541、その他に、用途別には、大腸がん、胃がん、固形腫瘍、腺がん、その他にセグメント区分し、セリンプロテインキナーゼの世界市場を分析しました。 ・エグゼクティブ・サマリー ・セリンプロテインキナーゼの世界市場概要 ・セリンプロテインキナーゼの製造コスト構成分析 ・セリンプロテインキナーゼの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・セリンプロテインキナーゼの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・セリンプロテインキナーゼのセグメント分析（種類別） （AZD-0156、AZD-1390、KU-55933、M-3541、その他）...The global Serine Protein Kinase market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Serine Protein Kinase volume and value at global level, regional level and company level. From a global perspective, this report represents overall Serine Protein Kinase market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Serine Protein Kinase in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界のチロシンプロテインキナーゼCSK市場 2019年
    DATA909X16990 / QYResearch / 2019年11月22日 / ※本調査レポートは、チロシンプロテインキナーゼCSKの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アパチニブ、ボスチニブ、CCT-196969、CCT-241161、その他に、用途別には、結腸がん、卵管がん、転移性乳がん、その他にセグメント区分し、チロシンプロテインキナーゼCSKの世界市場を分析しました。 ・エグゼクティブ・サマリー ・チロシンプロテインキナーゼCSKの世界市場概要 ・チロシンプロテインキナーゼCSKの製造コスト構成分析 ・チロシンプロテインキナーゼCSKの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・チロシンプロテインキナーゼCSKの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・チロシンプロテインキナーゼCSKのセグメント分析（種類別） （アパチニブ、ボスチニブ、CCT-196969、CCT-241161、その他）...The global Tyrosine Protein Kinase CSK market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Tyrosine Protein Kinase CSK volume and value at global level, regional level and company level. From a global perspective, this report represents overall Tyrosine Protein Kinase CSK market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Tyrosine Protein Kinase CSK in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界のチロシンプロテインキナーゼFyn市場 2019年
    DATA909X16991 / QYResearch / 2019年11月22日 / ※本調査レポートは、チロシンプロテインキナーゼFynの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ダサチニブ、マシチニブ、VAL-201、その他に、用途別には、アルツハイマー病、アルコール依存症、乳がん、がん性疼痛、その他にセグメント区分し、チロシンプロテインキナーゼFynの世界市場を分析しました。 ・エグゼクティブ・サマリー ・チロシンプロテインキナーゼFynの世界市場概要 ・チロシンプロテインキナーゼFynの製造コスト構成分析 ・チロシンプロテインキナーゼFynの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・チロシンプロテインキナーゼFynの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・チロシンプロテインキナーゼFynのセグメント分析（種類別） （ダサチニブ、マシチニブ、VAL-201、その他）...The global Tyrosine Protein Kinase Fyn market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Tyrosine Protein Kinase Fyn volume and value at global level, regional level and company level. From a global perspective, this report represents overall Tyrosine Protein Kinase Fyn market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Tyrosine Protein Kinase Fyn in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界のプロテインキナーゼ阻害剤市場 2019年
    DATA909X13844 / QYResearch / 2019年11月20日 / ※本調査レポートは、プロテインキナーゼ阻害剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、セリン/スレオニンプロテインキナーゼ阻害剤、チロシンプロテインキナーゼ阻害剤に、用途別には、治療、診断、研究にセグメント区分し、プロテインキナーゼ阻害剤の世界市場を分析しました。 ・エグゼクティブ・サマリー ・プロテインキナーゼ阻害剤の世界市場概要 ・プロテインキナーゼ阻害剤の製造コスト構成分析 ・プロテインキナーゼ阻害剤の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・プロテインキナーゼ阻害剤の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・プロテインキナーゼ阻害剤のセグメント分析（種類別） （セリン/スレオニンプロテインキナーゼ阻害剤、チロシンプロテインキナーゼ阻害剤）...The global Protein Kinase Inhibitor market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Protein Kinase Inhibitor volume and value at global level, regional level and company level. From a global perspective, this report represents overall Protein Kinase Inhibitor market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Protein Kinase Inhibitor in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界のRho結合プロテインキナーゼ市場 2019年
    DATA909X14408 / QYResearch / 2019年11月20日 / ※本調査レポートは、Rho結合プロテインキナーゼの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、AN-3485、KL-01045、AT-13148、TRX-101、その他に、用途別には、中枢神経系、接触性皮膚炎、線維症、その他にセグメント区分し、Rho結合プロテインキナーゼの世界市場を分析しました。 ・エグゼクティブ・サマリー ・Rho結合プロテインキナーゼの世界市場概要 ・Rho結合プロテインキナーゼの製造コスト構成分析 ・Rho結合プロテインキナーゼの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・Rho結合プロテインキナーゼの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・Rho結合プロテインキナーゼのセグメント分析（種類別） （AN-3485、KL-01045、AT-13148、TRX-101、その他）...The global Rho Associated Protein Kinase 1 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Rho Associated Protein Kinase 1 volume and value at global level, regional level and company level. From a global perspective, this report represents overall Rho Associated Protein Kinase 1 market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Rho Associated Protein Kinase 1 in North America, Europe, China, Japan, Southeast Asia and...
  • 世界の二重特異性プロテインキナーゼTTK市場 2019年
    DATA909X06869 / QYResearch / 2019年11月15日 / ※本調査レポートは、二重特異性プロテインキナーゼTTKの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、BAY-1217389、CCT-271850、CFI-402257、NMSP-153、NMSP-715、その他に、用途別には、固形腫瘍、大腸癌、膵管腺癌、その他にセグメント区分し、二重特異性プロテインキナーゼTTKの世界市場を分析しました。 ・エグゼクティブ・サマリー ・二重特異性プロテインキナーゼTTKの世界市場概要 ・二重特異性プロテインキナーゼTTKの製造コスト構成分析 ・二重特異性プロテインキナーゼTTKの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・二重特異性プロテインキナーゼTTKの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・二重特異性プロテインキナーゼTTKのセグメント分析（種類別） （BAY-1217389、CCT-271850、CFI-402257、NMSP-153、NMSP-715、その他）...The global Dual Specificity Protein Kinase TTK market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Dual Specificity Protein Kinase TTK volume and value at global level, regional level and company level. From a global perspective, this report represents overall Dual Specificity Protein Kinase TTK market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Dual Specificity Protein Kinase TTK in North America, Europe, China, Japan, Southeast Asia and...
  • 世界のチロシンプロテインキナーゼITK市場 2019年
    DATA909X16992 / QYResearch / 2019年11月22日 / ※本調査レポートは、チロシンプロテインキナーゼITKの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ARN-4079、GNE-4997、JTE-051、塩酸パゾパニブ、その他に、用途別には、喘息、軟骨肉腫、膠芽腫、転移性腎細胞癌、その他にセグメント区分し、チロシンプロテインキナーゼITKの世界市場を分析しました。 ・エグゼクティブ・サマリー ・チロシンプロテインキナーゼITKの世界市場概要 ・チロシンプロテインキナーゼITKの製造コスト構成分析 ・チロシンプロテインキナーゼITKの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・チロシンプロテインキナーゼITKの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・チロシンプロテインキナーゼITKのセグメント分析（種類別） （ARN-4079、GNE-4997、JTE-051、塩酸パゾパニブ、その他）...The global Tyrosine Protein Kinase ITK market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Tyrosine Protein Kinase ITK volume and value at global level, regional level and company level. From a global perspective, this report represents overall Tyrosine Protein Kinase ITK market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Tyrosine Protein Kinase ITK in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...

    • ◆H&Iグローバルリサーチのお客様（例）◆